These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7689754)

  • 21. Antithrombin III replacement in orthotopic liver transplantation.
    Coccheri S; Palareti G
    Semin Thromb Hemost; 1993; 19(3):268-72. PubMed ID: 8362256
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical use of synthetic antifibrinolytic agents during liver transplantation.
    Kang Y
    Semin Thromb Hemost; 1993; 19(3):258-61. PubMed ID: 8362255
    [No Abstract]   [Full Text] [Related]  

  • 23. Blood product use during orthotopic liver transplantation.
    Shan WL; Barkun J; Metrakos P; Tchervenkov J; Backman SB
    Can J Anaesth; 2004 Dec; 51(10):1045-6. PubMed ID: 15574559
    [No Abstract]   [Full Text] [Related]  

  • 24. Impact of aprotinin on blood transfusion requirements in liver transplantation.
    Smith O; Hazlehurst G; Brozovic B; Rolles K; Burroughs A; Mallett S; Dawson K; Mehta A
    Transfus Med; 1993 Jun; 3(2):97-102. PubMed ID: 7690641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of thromboelastometry in the assessment of hemostasis during orthotopic liver transplantation reduces the demand for blood products.
    Trzebicki J; Flakiewicz E; Kosieradzki M; Blaszczyk B; Kołacz M; Jureczko L; Pacholczyk M; Chmura A; Lagiewska B; Lisik W; Wasiak D; Kosson D; Kwiatkowski A; Lazowski T
    Ann Transplant; 2010; 15(3):19-24. PubMed ID: 20877262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Aprotinin reduces intraoperative bleeding during spinal arthrodesis interventions].
    Llau JV; Hoyas L; Higueras J; Ezpeleta J; García-Polit J
    Rev Esp Anestesiol Reanim; 1996 Mar; 43(3):118. PubMed ID: 8848642
    [No Abstract]   [Full Text] [Related]  

  • 27. Use of aprotinin in knee replacement surgery.
    Thorpe CM; Murphy WG; Logan M
    Br J Anaesth; 1994 Sep; 73(3):408-10. PubMed ID: 7524592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The intra-operative use of trasylol (aprotinin) in liver transplantation.
    Mallett SV; Cox D; Burroughs AK; Rolles K
    Transpl Int; 1991 Dec; 4(4):227-30. PubMed ID: 1723874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aprotinin in orthotopic liver transplantation.
    García L; Sabaté A; Domenech P; Martinez Brotons F; Drudis R; Jaurrieta E
    Transplant Proc; 1995 Aug; 27(4):2290-1. PubMed ID: 7544500
    [No Abstract]   [Full Text] [Related]  

  • 30. Use of aprotinin in the treatment of profuse incoercible bleeding during rhytidectomy.
    Larrea B; Llanos S; Roa R; Calderón W; Searle S
    Plast Reconstr Surg; 2007 Jan; 119(1):431-432. PubMed ID: 17255716
    [No Abstract]   [Full Text] [Related]  

  • 31. Reducing allogeneic transfusion in cardiac surgery: a randomized double-blind placebo-controlled trial of antifibrinolytic therapies used in addition to intra-operative cell salvage.
    Diprose P; Herbertson MJ; O'Shaughnessy D; Deakin CD; Gill RS
    Br J Anaesth; 2005 Mar; 94(3):271-8. PubMed ID: 15591329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A review of aprotinin in orthotopic liver transplantation: can its harmful effects offset its beneficial effects?
    Lentschener C; Roche K; Ozier Y
    Anesth Analg; 2005 May; 100(5):1248-1255. PubMed ID: 15845662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative effects of small and large aprotinin doses on bleeding during orthotopic liver transplantation.
    Soilleux H; Gillon MC; Mirand A; Daibes M; Leballe F; Ecoffey C
    Anesth Analg; 1995 Feb; 80(2):349-52. PubMed ID: 7529468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can we really believe that aprotinin is safe in congenital heart surgery?
    Faraoni D
    Ann Thorac Surg; 2011 Mar; 91(3):987-8; author reply 988. PubMed ID: 21353050
    [No Abstract]   [Full Text] [Related]  

  • 35. Aprotinin in children undergoing correction of congenital heart defects. A double-blind pilot study.
    Herynkopf F; Lucchese F; Pereira E; Kalil R; Prates P; Nesralla IA
    J Thorac Cardiovasc Surg; 1994 Sep; 108(3):517-21. PubMed ID: 7521498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the effects of aprotinin and tranexamic acid on blood loss and red blood cell transfusion requirements during the late stages of liver transplantation.
    Ickx BE; van der Linden PJ; Melot C; Wijns W; de Pauw L; Vandestadt J; Hut F; Pradier O
    Transfusion; 2006 Apr; 46(4):595-605. PubMed ID: 16584436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of reduced aprotinin dosage on blood loss and use of blood products in patients undergoing cardiopulmonary bypass.
    Liu B; Belboul A; Rådberg G; Tengborn L; Dernevik L; Roberts D; William-Olsson G
    Scand J Thorac Cardiovasc Surg; 1993; 27(3-4):149-55. PubMed ID: 7515193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The effects of aprotinin. Blood loss and coagulation parameters in orthotopic liver transplantation: A clinical-experimental, prospective and randomized double-blind study].
    Kratzer MA; Azad SC; Groh J; Welte M; Haller M; Pratschke E
    Anaesthesist; 1997 Apr; 46(4):294-302. PubMed ID: 9229983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intraoperative use of aprotinin (Trasylol) in orthotopic liver transplantation.
    Mallett S; Rolles K; Cox D; Burroughs A; Hunt B
    Transplant Proc; 1991 Jun; 23(3):1931-2. PubMed ID: 1712134
    [No Abstract]   [Full Text] [Related]  

  • 40. Reduction of blood loss using high-dose aprotinin in major orthopaedic surgery.
    Slappendel R; Dirksen R; Van Hellemondt GG
    J Bone Joint Surg Br; 2004 May; 86(4):620; author reply 620-1. PubMed ID: 15174566
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.